Boston Biotech Business Development Conference

Boston Biotech Business Development Conference

Speaking Engagement
The Boston Biotech Business Development Conference is a networking forum for industry professionals offering exclusive access to key decision-makers who influence deal-making and investment in the life sciences. Attendees will gain insights from presentations and panels featuring business development decision-makers from several of the world's leading pharmaceutical and biotechnology companies on the current and future outlook for licensing, M&A and other business development activities in the life sciences sector. In addition to sharing insights on what it takes to get a deal done in biotech, the conference will also offer opportunities to network one-on-one with the industry's top deal makers, including senior executives from biotech and pharma, leaders from Wall Street and venture capitalists.

WilmerHale Partner Hal Leibowitz will moderate a panel titled “M&A Activity in 2013: Who Benefits Most, Pharma or Biotech?” on Tuesday, April 2 from 4–4:30 p.m., and WilmerHale Partner David Redlick will moderate a panel titled “The Deals of Tomorrow: Predictions and Wish Lists” on Wednesday, April 3 from 3–3:30 p.m.

Read More About the Event

Speakers

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.